还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

$ W# \4 e( }( U5 t! x请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  
9 g: j3 S! Z$ B0 {. y& V
+ z& D  V* c3 |7 |" j8 K. L
Sub-category:
8 U) ]$ u3 [. ]* yMolecular Targets

; p, _: G: y0 Y8 r: }
Category:
6 H# _- y/ |) l( @Tumor Biology

1 e) o( k6 A' f0 y% Q9 ]" u
Meeting:
2011 ASCO Annual Meeting


Session Type and Session Title:
! }& Z% q4 m: }1 X  ?( a; }Poster Discussion Session, Tumor Biology
; K8 C' L8 c4 ?( U, X

5 `, \/ _2 [. B: w- KAbstract No:
10517

: P; A$ h# I& a7 U. ~0 l2 T/ `
Citation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)


- K" K3 A1 r5 j4 H1 B) [; J" ZAuthor(s):
" o& F. k; D9 {' b. HJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

* s/ z1 r- J0 P3 {8 O( w
+ }8 G/ A  T$ Q  u2 l
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

* I1 D! j+ Q  t" B0 ]% Y+ WAbstract Disclosures
3 x2 \0 ]4 P5 s5 ]
- t0 L- u' a" Q) s: ^. ~( DAbstract:
+ w$ _9 j4 Z+ J4 K2 `3 g) c) [2 M
3 U0 ?! b7 _% Z+ J. c! p) J8 F
Background: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.
( Y1 s) W' P% Z( k7 e6 R: @

4 a/ p3 h* i3 x

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

) p- c1 m8 R/ w4 j) {% ~  e& {4 V. N                               
登录/注册后可看大图

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

                               
登录/注册后可看大图

6 ^) \' b! E! S1 Q+ y易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
8 e: j6 i. T7 x9 y+ |1 [ALK一个指标医院要900多 ...

2 l- r! R2 ?, ~4 C: x. g& u平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
+ U+ a4 S3 z0 P9 ^6 ^6 t$ @
现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊